Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Abortion Drugs
86 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
86 results
Abortion Drugs

Overlooked Dangers of Mifepristone, the FDA’s Reduced REMS, and Self-Managed Abortion Policies: Unwanted Abortions, Unnecessary Abortions, Unsafe Abortions

The failure of abortion providers to support and undertake prospective longitudinal studies of a nationally representative sample of women contributes…

David C. Reardon, Ph.D. Donna Harrison, M.D.
December 16, 2021
Please login to bookmark Close
Abortion Drugs

Public Health Threat: Connecticut DPH Data Shows More Women Using Risky Abortion Method

Half of all Connecticut abortions are performed with potentially dangerous drugs which multiple peer-reviewed studies have linked to higher rates…

Abortion Drugs

Public Health Threat: Colorado DPHE Data Reveals Dramatic Increase in Risky Abortion Method

The most recent State of Colorado abortion data shows a dramatic increase in the use of potentially dangerous abortion drugs…

Abortion Drugs

Public Health Threat: Chemical Abortion Leads to Significantly Higher Rate of ER Visits

As the Food and Drug Administration (FDA) works toward a December 16 decision on chemical abortion safeguards, a groundbreaking new…

featured-image
Abortion Drugs

A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015

Existing research on postabortion emergency room visits is sparse and limited by methods which underestimate the incidence of adverse events…

featured-image
Abortion Drugs

Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019

Objectives: Primary: Analyze the Adverse Events (AEs) reported to the Food and Drug Administration (FDA) after use of mifepristone as…

featured-image
Abortion Drugs

Health Risk: Alaska DHSS Data Reveals Dramatic Increase in Risky Abortion Method

The most recent Alaska Department of Health and Social Services abortion data shows a dramatic increase in the number of…

Abortion Drugs

Abortion Pill Reversal: A Record of Safety and Efficacy

Chemical abortions have been increasing over recent years to now account for 44 percent of reported abortions in the United…

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image